5q- Survival: Importance of Gender and Deleted 5q Bands and Survival Analysis Based on 324 Published Cases

References

• Kerkhofs H., Hagemeier A., Leeksma C. H.W., Abels J., Ottolander Gi. D., Somers R., Gerrits W. B.J., LangenhuiŸEn M. M.A.C, Borne A. E.G.K.V., Van Hemel J. O., Geraedts J. P.M. The 5q- chromosome abnormality in haematological disorders: a collaborative study of 34 cases from the Netherlands. British Journal of Haematology 1982; 52: 365–381
   PubMed Web of Science ®Google Scholar
• Van Den Berghe H., Vermaelen K., Mecucci C., Barbieri D., Tricot G. The 5q- anomaly. Cancer Genetics and Cytogenetics 1985; 17: 189–255
   PubMed Web of Science ®Google Scholar
• Dewald G. W., Davis M. P., Pierre R. V., O'Fallon J. R., Hoagland H. C. Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5. Blood 1985; 66: 189–197
   PubMed Web of Science ®Google Scholar
• Pedersen B., Jensen I. M. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. Leukemia 1991; 5: 566–573
   PubMed Web of Science ®Google Scholar
• Pedersen B. Anatomy of the 5q- deletion. Different sex ratios and deleted 5q bands in MDS and AML. Leukemia 1996; 10: 1883–1890
   PubMed Web of Science ®Google Scholar
• Petit P., Van Den Berghe H. The 5q- and additional chromosome anomalies in two patients with acute myeloid leukemia. Annales de Génétique 1979; 22: 103–105
   PubMedGoogle Scholar
• Swolin B., Weinfeld A., Ridell B., Waldenstrom J., Wes-Tin J. On the 5q-deletion: Clinical and cytogenetic observations in ten patients and review of the literature. Blood 1981; 58: 986–993
   PubMed Web of Science ®Google Scholar
• Hartley S. E., McCallum C. J. The 5q- chromosome in a case of erythroid hypoplasia. Cancer Genetics and Cytogenetics 1981; 3: 33–36
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Bloomfield C D., Ensrud K. All patients with acute nonlymphocytic leukemia may have a chromosomal defect. New England Journal of Medicine 1981; 305: 135–139
   PubMed Web of Science ®Google Scholar
• Kardon N., Schulman P., Degnan T. J., Budman D. R., Davis J., Vinciguerra V. Cytogenetic findings in the dysmyelopoietic syndrome. Cancer 1982; 50: 2834–2838
   PubMed Web of Science ®Google Scholar
• Mecucci C., Donti E., Bocchini V., Tabilio A., Martelli M. F. 5q- syndrome in a patient with chronic exposure to ionizing radiation. Cancer Genetics and Cytogenetics 1982; 5: 75–80
   PubMed Web of Science ®Google Scholar
• Vermaelen K., Barbieri D., Michaux J.-L., Tricot G., Casteels-Van Daele M., Noens L., Van Hove W., Drochmans A., Louwagie A., Van Den Berghe H. Anomalies of the long arm of chromosome 11 in human myelo- and lymphoproliferative disorders. I. Acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics 1983; 10: 105–116
   PubMed Web of Science ®Google Scholar
• Tinegate H., Gaunt L., Hamilton P. J. The 5q- syndrome: an underdiagnosed form of macrocytic anaemia. British Journal of Haematology 1983; 54: 103–110
   PubMed Web of Science ®Google Scholar
• Taniwaki M., Edagawa J., Sonoda Y., Nishida K., Misawa S., Abe T., Takino T., Arizono N. Cytogenetic evidence of clonal evolution in a case of hemopoietic dysplasia with a 5q- chromosome. Cancer Genetics and Cytogenetics 1983; 10: 59–65
   PubMed Web of Science ®Google Scholar
• Xavier A. M., Kasimis B. S. Chronic anemia progressing to Auer rod-positive and TdT-positive acute leukemia with 5q- chromosomal anomaly. American Journal of Hematology 1984; 17: 409–416
   PubMed Web of Science ®Google Scholar
• Johnson D. D., Dewald G. W., Pierre R. V., Letendre L., Silverstein M. N. Deletion of chromosome 13 in malignant hematologic disorders. Cancer Genetics and Cytogenetics 1985; 18: 235–241
   PubMed Web of Science ®Google Scholar
• Testa J. R., Misawa S., Oguma N., Sloten K. V., Wiernik P. H. Chromosomal alterations in acute leukemia patients studied with improved culture methods. Cancer Research 1985; 45: 430–434
   PubMed Web of Science ®Google Scholar
• Gyger M., Perreault C., Pichette R., Forrest L., Lussier P. Interstitial deletion of the long arm of chromosome 5 (5q-) in leukemia and other hematological disorders: clinical and biological relevance of variable breakpoint patterns. Leukemia Research 1986; 10: 9–15
   PubMed Web of Science ®Google Scholar
• Baer M. R., Dessypris E. N. Deletion of the long arm of chromosome 5 (5q-) as a secondary event in the course of refractory anemia. Cancer Genetics and Cytogenetics 1986; 22: 169–176
   PubMed Web of Science ®Google Scholar
• Jacobs R. H., Cornbleet M. A., Vardiman J. W., Larson R. A., Le Beau M. M., Rowley J. D. Prognostic implications of morphology and karyotype in primary myelo-dysplastic syndromes. Blood 1986; 67: 1765–1772
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Albain K. S., Larson R. A., Vardiman J. W., Davis E. M., Blough R. R., Golomb H. M., Rowley J. D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. Journal of Clinical Oncology 1986; 4: 325–345
   PubMed Web of Science ®Google Scholar
• Mecucci C., Tricot G., Boogaerts M., Van Den Berghe H. An identical translocation between chromosome 1 and 15 in two patients with myelodysplastic syndrome. British Journal of Haematology 1986; 62: 439–445
   PubMed Web of Science ®Google Scholar
• Misawa S., Hogge D. E., Oguma N., Wiernik P. H., Testa J. R. Detection of clonal karyotypic abnormalities in most patients with acute nonlymphocytic leukemia examined using short-term culture techniques. Cancer Genetics and Cytogenetics 1986; 22: 239–251
   PubMed Web of Science ®Google Scholar
• Mitelman F., Manolova Y., Manolov G., Billstrom R., Heim S., Kristoffersson U., Mandahl N. High resolution analysis of the 5q- marker chromosome in refractory anemia. Hereditas 1986; 105: 49–54
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Rydell R. E., Oken M. M., Arnesen M. A., Mayer M. G., Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 67: 1721–1730
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Philip P. Cytogenetic characteristics of therapy-related acute nonlymphocytic leukemia, preleukemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases. British Journal of Haematology 1987; 66: 199–207
   PubMed Web of Science ®Google Scholar
• Rege-Cambrin G., Mecucci C., Tricot G., Louwagie A., Van Hove W., Francart H., Van Den Berghe H. A chromosomal profile of polycythemia vera. Cancer Genetics and Cytogenetics 1987; 25: 233–245
   PubMed Web of Science ®Google Scholar
• Horiike S., Taniwaki M., Misawa S., Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988; 62: 1129–1138
   PubMed Web of Science ®Google Scholar
• Larson R. A., Wernli M., Le Beau M. M., Daly K. M., Pape L. H., Rowley J. D., Vardiman J. W. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood 1988; 72: 1333–1339
   PubMed Web of Science ®Google Scholar
• Whang-Peng J., Young R. C., Lee E. C., Longo D. L., Schechter G. P., Devita V. T.J. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 1988; 71: 403–414
   PubMed Web of Science ®Google Scholar
• Gyger M., Forrest L., Lussier P., D'Angelo P., Desy M. Translocation (1;5)(-q23;q33) in adult acute non-lymphocytic leukemia. European Journal of Hematology 1989; 42: 246–249
   PubMed Web of Science ®Google Scholar
• Iurlo A., Mecucci C., Van Orshoven A., Michaux J.-L., Boogaerts M., Noens L., Bosly A., Louwagie A., Van Den Berghe H. Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome. Cancer Genetics and Cytogenetics 1989; 43: 227–241
   PubMed Web of Science ®Google Scholar
• Smadja N., Krulik M., Gramont A. D., Gonzalez-Canali G., Audebert A. A., Debray J. Refractory anemia with excess of blasts in transformation: Clinical hematological, and cytogenetic findings in nine patients. Cancer Genetics and Cytogenetics 1989; 42: 55–65
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Kaneko Y., Maseki N., Sakurai M. Karyotypically unrelated clones in acute leukemias and myelodysplastic syndromes. Cancer Genetics and Cytogenetics 1990; 47: 171–178
   PubMed Web of Science ®Google Scholar
• Lai J. L., Zandecki M., Fenaux P., Le Baron F., Bauters F., Cosson A., Deminatti M. Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics 1990; 47: 173–183
   Web of Science ®Google Scholar
• Jotterand-Bellomo M., Parlier V., Schmidt P. M., Beris P. Cytogenetic analysis of 54 cases of myelodysplastic syndrome. Cancer Genetics and Cytogenetics 1990; 46: 157–172
   PubMed Web of Science ®Google Scholar
• Rubin C M., Larson R. A., Anastasi J., Winter J. N., Thangavelu M., Vardiman J. W, Rowley J. D., Le Beau M. M. t(3:21)(q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 1990; 76: 2594–2598
   PubMed Web of Science ®Google Scholar
• Suciu S., Kruse R., Weh H. J., Hossfeld D. K. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genetics and Cytogenetics 1990; 44: 15–26
   PubMed Web of Science ®Google Scholar
• Ohyashiki K., Sasao I., Ohyashiki J. H., Murakami T., Iwabuchi A., Tauchi T., Saito M., Nakazawa S., Serizawa H., Ebihara Y., Toyama K. Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis. Cancer 1991; 68: 178–183
   PubMed Web of Science ®Google Scholar
• Gyger M., D'Angelo P., BÉLanger R., Forrest L., Lussier P., Busque L., Perreault C., Boileau J., Bonny Y., Lavallee R., Lacombe M., Roy D.-C. Cytogenetic characterisation of primary refractory anemia. American Journal of Hematology 1992; 41: 241–248
   PubMed Web of Science ®Google Scholar
• Olopade O. I., Thangavelu M., Larson R. A., Mick R., Kowal-Vern A., Schumacher H. R., Le Beau M. M., Vardiman J. W., Rowley J. D. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 1992; 80: 2873–2882
   PubMed Web of Science ®Google Scholar
• Wong K. F., Chan J. K.C., Chu Y. C., Kwong Y. L. Clonal evolution in primary 5q- syndrome. Cancer 1992; 70: 100–103
   PubMed Web of Science ®Google Scholar
• Swolin B., Kristiansen I. H., Rodjer S., Hellstrom-Lindberg E. Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes. Leukemia Research 1993; 17: 927–932
   PubMed Web of Science ®Google Scholar
• Nagarajan L., Zhao L., Lu X., Warrington J. A., Wasmuth J. J., Siciliano M., Deisseroth A. B., Liang J. C. 5q-chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts. Cancer Genetics and Cytogenetics 1994; 74: 8–12
   PubMed Web of Science ®Google Scholar
• Lewis S., Oscier D., Boultwood J., Ross E., Fitchett M., Rack K., Abrahamson G., Buckle V., Wainscoat J. S. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion. American Journal of Hematology 1995; 49: 194–200
   PubMed Web of Science ®Google Scholar
• Uyttebroeck A., Brock P., De Groote B., Renard M., Cin P. D., Van Den Berghe H., Casteels-Van Daele M. 5q- syndrome in a child. Cancer Genetics and Cytogenetics 1995; 80: 121–123
   PubMed Web of Science ®Google Scholar
• Palmar M. K.B., Machin D. Survival Analysis. A Practical Approach. John Wiley and Sons, Chichester 1995; pages 151–154
   Google Scholar
• Sachs L. Applied Statistics. A Handbook of Techniques. Springer-Verlag, New York 1978
   Google Scholar
• Pedersen B. 5q-: Does longer survival of female patients explain the female preponderance?. Anticancer Research 1997; 17: 3281–3286
   PubMed Web of Science ®Google Scholar